nih seed logoBioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary that translates market-relevant research into commercial success by bringing together management, funding, and markets. BHI is seeking two experienced life science professionals with product development and investment experience to join the BHI team to serve as a part-time Entrepreneurs-in-Residence (EIR) at the National Institutes of Health (NIH).

These positions will report to and work closely with our lead at the NIH Small business Education and Entrepreneurial Development (SEED) Office to support academic and small business innovators in their efforts to validate the potential health impacts of promising scientific discoveries and advance them into healthcare products that improve patient care and enhance health.

Click here to download the full job description.

MCDEC LogoDownload the Program Book

MARCH 17

8:45 a.m. - Networking via Zoom Chat

9:00 a.m. - Welcome/Logistics—Judy Costello, Managing Director, BioHealth Innovation, Inc. (BHI)

9:00 a.m. – 4:00 p.m. - 1:1 Meetings with Program Officers*

9:05 a.m. - Overview:  SBIR/STTR Funding Opportunities at the NIH – Stephanie FertigHHS
                    Small Business Program Lead, National Institutes of Health 
(NIH)     (SLIDES) (VIDEO)

     Institute Insights re SBIR/STTR Funding Opportunities  

       9:20 a.m. - National Heart, Lung, and Blood Institute Stephanie Davis, PhD - Small Business Program
                          Coordinator, NHLBI (SLIDES)

       9:35 a.m. - National Institute on Aging - Saroj Regmi, PhD - Health Science Administrator Office of Small
                          Business Research, NIA  (SLIDES)

      9:50 a.m. - National Institute on Drug Abuse - Elena Koustova, PhD, MBA—Director, Office of Translational
                         Initiatives and Program Innovations (OTIPI), NIDA, SBIR/STTR Coordinator, NIDA Office of Director

     10:05 a.m. - National Cancer Institute Reema Railkar, PhD - Program Manager, NIH National Cancer -  (SLIDES)

                         Institute SBIR Development Center
     10:20 a.m. - National Institute of Allergy and Infectious Diseases - Natalia Kruchinin, PhD SBIR/STTR
                          Program Coordinator, RTSP, DEA

10:35 a.m. - Q&A with all NIH speaker

10:50 a.m. - Networking via Zoom Chat
11:00 a.m. - SBIR Funding Opportunities at the National Science Foundation -
Ben Schrag - Program Director, NSF  (SLIDES) (VIDEO)

11:30 am. - Military Medical SBIR/STTR Contract Opportunities - JR Myers, SBIR Project Manager, USAMRDC - (SLIDES) (VIDEO)

12:00 p.m. - Writing Your Specific Aims Page Deepa Narayanan - Program Director and Team Lead, NIH National
                     Cancer Institute 
SBIR Development Center - (SLIDES) (VIDEO)

12:30 p.m. - Writing Your Phase II Commercialization Plan - Todd Haim, PhD - Chief, Office of Small Business
                     Research, NIA - (SLIDES) (VIDEO)

1:00 p.m. – Networking via Zoom Chat

1:30 p.m. - Funding Projects thru MIPS at the University of Maryland - Onur Unal, Manager, Life Sciences Projects,
                   Maryland Industrial Partnerships (MIPS), Maryland Technology Enterprise Institute (MTech) - (SLIDES) (VIDEO)

2:00 p.m. - Tips for a Winning Application - Rini Pek, Senior Analyst, BioHealth Innovation, Inc. (BHI) and Ashwin
                   Kulkarni, COO, miRecule -  (SLIDES) (VIDEO)

Until 4:00 p.m. - 1:1 Meetings with Program Officers Continue*

MARCH 18

1:1 Partnering Meetings with Program Officers Continue 9:00 a.m. - 4:00 p.m.*

9:30 a.m. - Networking via Zoom Chat

10:00 a.m. - Local Government Resources to Support Innovation—Resources to help you find space, build out yourfirst lab, incentivize potential angel investors, support your R&D and job growth, and MORE!  Lynne Stein Benzion, Director, Economic Development, Montgomery County Economic Dev. Corp.Sharon Disque, Economic Development Manager, City of Gaithersburg, MDCarla Merritt, Senior Business Development Representative, Maryland Department of CommerceModerator: Judy Costello, Managing Director, BioHealth Innovation, Inc. (BHI) (VIDEO)

11:00 a.m. - You Are Working on Non-Dilutive Funding, What's Next? —Next steps and additional resources togrow your company—informative conversation with Q&A. Ethel Rubin and John Sullivan,Entrepreneurs-in-Residence, BioHealth Innovation, Inc. and Anthony Saleh, CEO, miRecule - (SLIDES)

12:00 p.m. 1:1 Partnering Meetings with Program Officers Continue until 4:00 p.m.*

MARCH 19

9:00 a.m. - 4 p.m. - 1:1 Partnering Meetings with Program Officers Continue

EIR logo


There is a large gap between disruptive technological innovations in Universities and federal labs and commercially relevant technologies that enter the market. One of the principal reasons for this gap is the absence of resources (entrepreneurs, knowledge base, capital, etc) to facilitate the movement of the technology along the commercialization path.

The Entrepreneur-in-Residence Program at BHI is aimed at ensuring that disruptive technologies receive all the resources that are required to transform the technology from a discovery into a commercially relevant product and eventually have a measurable impact on human health. The program has been created to support scientists, early stage start-ups and licensed technologies to provide them with access to these resources.

The BHI SBIR/STTR Federal Funding Assistance Program offers biohealth companies support in preparing applications for federal funding inclusive of SBIRs, STTRs, and other federal government awards. Companies submit their federal funding concepts and receive pre-proposal feedback to help troubleshoot and strengthen your application. Further support from professional consultants and service providers is available to assist in improving your application.

Read more...

worksource montgomery logoTo post job/internship opportunities, please email This email address is being protected from spambots. You need JavaScript enabled to view it. your request with the link/URL to your specific opportunity or to your page highlighting multiple opportunities.  Please also notify us once these position(s) are filled. Thank you.

 

3i Diagnostics, Inc. - Gaithersburg

Advanced BioScience Laboratories, Inc. (ABL) - Rockville

Aledade – Bethesda

Altimmune - Gaithersburg

Amarex Clinical Research – Germantown

American Gene Technologies – Rockville

Aphena – Easton

ARPA-H - Bethesda

AstraZeneca  – Frederick, Gaithersburg

ATCC – Gaithersburg, MD and Manassas, VA

Aurinia Pharmaceuticals – Rockville

Autolus – Gaithersburg, Rockville

b well - Baltimore

BioFactura - Frederick  

Cartesian Therapeutics  –  Gaithersburg

Catalent – Harmans

Champions Oncology, Inc. - Rockville

Children's National - DC

DrFirst – Rockville

Early Charm - Baltimore

Elixirgen Scientific - Baltimore

Ellume - Frederick

Emergent BioSolutions, Inc. - Baltimore, Gaithersburg, Rockville

EMMES Corp - Frederick, Rockville

Emocha Mobile Health, Inc.  – Baltimore

Frederick National Lab for Cancer Research - Frederick

GetWellNetwork, Inc. - Bethesda

GSK Global Vaccines US R&D Center - Rockville

GlycoMimetics, Inc. - Rockville

Henry Jackson Foundation – Bethesda and Silver Spring, MD

Horizon Therapeutics – Gaithersburg

Immunomic Therapeutics - Rockville

Institute for In Vitro Sciences - Gaithersburg

Intralytix - Baltimore and Columbia

Jecho Laboratories - Frederick

Johns Hopkins Technology Ventures – Baltimore

Johnson & Johnson – DC and Gaithersburg

KeyGene USA - Rockville

Kite Pharma (a Gilead Company) – Frederick, Gaithersburg

Landos Biopharma, Inc. – Reston

Leadiant Biosciences - Gaithersburg

Leidos Biomedical Research - Frederick

Lieber Institute for Brain Development – Baltimore

Lonza - Walkersville

Lupin Pharmaceuticals, Inc. - Baltimore

MacroGenics - Rockville

Maryland Department of Commerce - Baltimore

MaxCyte, Inc. – Gaithersburg

Maxim Biomedical – Rockville

Meso Scale Diagnostics – Rockville, Gaithersburg

Miltenyi Biotec - Gaithersburg

Mimetas - Gaithersburg

National Institutes of Health (NIH) - Bethesda

Netrias- Bethesda and Arlington

NexImmune - Gaithersburg

Nobile Life Sciences - Baltimore

Novavax, Inc. - Gaithersburg, Rockville

Novel MicroDevices - Baltimore

Noxilizer – Baltimore

Precigen – Germantown

Protenus - Baltimore

QIAGEN Sciences - Germantown, Frederick

Quality Biological - Gaithersburg, MD and D.C.  

REGENXBIO Inc. - Rockville

RoosterBio, Inc. – Frederick

Root3Labs - Randallstown

Sanaria, Inc. - Rockville

SeraCare - Gaithersburg

Senseonics - Germantown

Sirnaomics – Gaithersburg

Smith & Nephew - Columbia, MD

SoBran - Bethesda, Baltimore, Poolesville, Silver Spring

Sonavex Surgical, Inc. - Baltimore

Sterilex – Hunt Valley

Supernus Pharmaceuticals – Rockville

ThermoFisher Scientific - Baltimore, Bethesda, Frederick, DC

United Therapeutics - Silver Spring

University of Maryland Medical System - Maryland

U.S. Food and Drug Administration (FDA)

US Pharmacopeia - Rockville

Vaccitech - Maryland

Vanda Pharma - D.C.

Vheda Health - Columbia

WellDoc - Columbia

Westat - Rockville

maryland-department-of-commerce-logo.png

BioParks 2017 is an opportunity to learn from biotech industry leaders, who share their data, experience, insights and vision. We will explore trends in life science research, funding resources, the marriage of life science and engineering and global partnership opportunities. Translating discoveries from the laboratory to the market has never been more important.

https://www.kitchology.com/

For the 160 million consumers in the US with personalized diets, Kitchology is a social cooking platform that helps users rediscover the world of food by empowering them to customize and shop for recipes they will love. It is a free mobile app and website that supports meal planning and shopping online and/or in stores. For suppliers, Kitchology is a brand engagement and data analytics platform that allows manufacturers and retailers alike to actively engage with consumers and assist them in meal planning and shopping, avoid out of stock situations and get insight into behaviors. For wellness providers, Kitchology is a patient engagement platform and data analytics tool that allows wellness providers to actively engage with consumers through meal planning and shopping, and gain insight into patient behavior and outcome.

Kitchology

 

 

LinkedIn
Twitter
Facebook
YouTube
Instagram
Pinterest

http://uverj.com/

ConVerjing major retailers and consumers by combining the power of best pricing with existing infrastructure and added levels of security to empower:

- Retailers to leverage the robust reporting and dynamic pricing capability of an ecommerce channel to potentially capture sales that may otherwise have been lost.

- Consumers to access major retailers on one easy-to-use site, getting the best possible price for all of their purchases.

Uverj

 

mckinsey-company-logo

The US healthcare industry is undergoing a major transformation as healthcare reform encourages consumers to play a far more active decision-making role. Yet despite this traditionally business-to-business industry moving quickly to a business-to-consumer model, companies have been slow to join the digital movement. Unlike successful B2C companies in other industries—which offer mobile solutions, provide personalized product recommendations, and empower customer-service agents with a 360-degree view of the customer—most healthcare providers and payors are lagging, as are pharmaceutical companies and medical-device manufacturers

vheda-health-logo

Vheda Health, a digital health company that seeks to help people with chronic conditions, is one of a handful of healthcare startups that have received backing from a commercialization fund from Maryland’s Technology Development Corp. They were part of a list of 15 companies that received $1.5 million. It follows a funding allocation from earlier this year.

digi-capital-mobile-investment-image

Mobile Internet companies raked in a total of $19.2 billion in new investment over the last year, more than double the previous period, according to investment advisory firm Digi-Capital.

The big winner? Mobile commerce, with $4.2

uk-trade-logo

To attend a NICE/UKTI Scientific Advice Seminar for developers of devices and diagnostics.

Learn how to prepare for an evaluation by NICE, the UK’s health technology assessment body.

The seminar will cover:

  • "Value" from the perspective of NICE
  • How value propositions link to the need for specific evidence
  • The types of evidence considered by NICE
  • The general principles of health technology assessment (HTA)
  • Advantages of doing business in the UK

Who should attend?

  • Developers of medical technologies, in particular SMEs
  • Investors in the field of medical technologies
  • Anyone new to the world of health technology assessment
  • Academics, scientists, or clinicians who want to know more about how NICE assesses the value of innovative products

The seminar program is funded by UKTI to allow you free event registration (standard event rate - $550)